Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million
10/08/2026 12:01
BRIEF-Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million Aug 10 (Reuters) - Jade Biosciences, Inc Q2 net income USD -55.8 million vs. IBES estimate USD -42.1 million.
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million